Nippon India Mutual FundIndex: Sector & ThematicDirect plan, growth

Nippon India Nifty Pharma ETF

Compare index: sector & thematic funds Compare with others

NAV: ₹27.28; —11 Sept 2026
AUM (₹ Cr): 1,458; Average, April - June 2026
Expense ratio: 0.23%; Direct plan
Risk: Very High; SEBI riskometer

1Y return: 19.8%-0.9%; Benchmark 20.8%
3Y CAGR: 20.6%-0.4%; Benchmark 21.1%
5Y CAGR: 13.7%-0.3%; Benchmark 13.9%

Loading NAV history…

Nippon India Nifty Pharma ETF

Calendar-year returns

Fund only: no comparison series covers this fund's history.

Risk statistics

Five years of daily NAVs. Risk-free rate 6.5% a year.

Standard deviation: —
Maximum drawdown: —
Sharpe ratio: —
Sortino ratio: —
Beta: —
Alpha: —
R²: —
Information ratio: —
Upside capture: —
Downside capture: —
Tracking error: —

Trailing returns compared with benchmark
Period	1M	3M	6M	YTD	1Y	3YCAGR	5YCAGR	10YCAGR	LaunchCAGR
Fund	-0.9%	+9.0%	+16.5%	+17.2%	+19.8%	+20.6%	+13.7%	—	+13.1%
Nifty Pharma TRI	—	—	—	—	20.8%	21.1%	13.9%	—	13.4%
Index: Sector & Thematic average	-3.0%	1.6%	8.3%	-3.5%	0.2%	2.5%	0.3%	2.1%	4.1%
Difference	—	—	—	—	-0.9%	-0.4%	-0.3%	—	-0.3%

Portfolio

Fund details

Fund house: Nippon India Mutual Fund
Category: Equity · Index: Sector & Thematic
SEBI classification: Other / Index Funds ETFs
Benchmark: Nifty Pharma TRI
Launch date: 6 Jul 2021 (5.2 years)
Structure: Open Ended · ETF
Plans and options: Direct Growth
Riskometer: Very High (benchmark Very High)
Expense ratio as of: 9 Sept 2026
AUM period: April - June 2026
ISIN, Direct Growth: INF204KC1089
Scheme code: 149008

NAV and returns as of 11 Sept 2026; returns are for the direct plan, growth option, before entry or exit costs. Not investment advice.

Other index: sector & thematic funds

Other funds in the Index: Sector & Thematic category.

Compare index: sector & thematic funds